The pea-sized device is implanted behind the iris of one eye. The FDA-approved procedure does not reverse AMD, but may improve vision for those who are legally blind from the condition.
Candidates for the surgery are 75 and older with irreversible end-stage AMD and are no longer candidates for drug-based treatment. They must have vision ranging between 10/160 and 20/800, and may not have undergone cataract surgery in the eye in which the device would be implanted.
More Articles on Eye Surgery:
Glaucoma Drug Latanoprostene Bunod Enters Trial Phase 3
10 Milestones for Ambulatory Surgery Centers
3 Reasons LASIK Surgery is More Popular in the Winter
